News

On this page, you can find recent news concerning the Anticancer Fund, cancer, and cancer therapies.

Anticancer Fund News

Cures Within Reach PRESS RELEASE: A New Initiative Sponsored by Cures Within Reach

News source: 
Anticancer Fund

'Cures Within Reach' is a Boston-based initiative that aims to fund and facilitate the development of new cancer treatments based on repurposing of generic drugs previously approved by the Food and Drug Administration for other indications.

A new guide for patients available - Non-Conventional Treatment Options in Breast Cancer

News source: 
Anticancer Fund

Thanks to the financial support of the lingerie firm Van de Velde the guide “Non-Conventional Treatment Options in Breast Cancer” was created by a team of scientists at the Anticancer Fund.

FDA press release: FDA takes action against 14 companies for selling illegal cancer treatments

News source: 
Anticancer Fund

14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer.

New guide for patients available on nutrition in cancer cachexia

News source: 
Anticancer Fund

Cachexia is a problem that doesn’t receive enough attention during a cancer treatment.

Press release: Common Heart Drug Repurposed to Treat Rare Cancer in Europe

News source: 
Anticancer Fund

Orphan Drug Designation Confirms Propranolol’s Treatment Benefits

Growing evidence that exercise is safe and beneficial for cancer patients and cancer survivors.

News source: 
Anticancer Fund

Recent findings on breast cancer confirm that exercise may decrease fatigue and increase energy during breast cancer treatment.

PIONEER: a randomised Phase II trial in early stage, operable ER+ breast cancer patients - new publication in 'Nature Reviews Cancer'

News source: 
Anticancer Fund

A new paper in the journal Nature Reviews Cancer, ‘Deciphering the divergent roles of progestogens in breast cancer’, outlines the complex role of progestogens in ER positive breast cancer.

Press release: First patient enrolled in brain tumor trial combining 9 repurposed drugs - CUSP9v3

News source: 
Anticancer Fund

The Anticancer Fund is pleased to announce that on Tuesday 15th November 2016, the first patient was enrolled in a clinical trial called CUSP9v3 for recurrent glioblastoma at the Department of Neurosurgery, University Hospital of Ulm, Germany.

Pers release: It's time to consider propranolol as an anti-cancer drug, researchers say

News source: 
Anticancer Fund

The common beta-blocker has significant anti-cancer properties.

New data from a retrospective study with aspirine in advanced colorectal cancer patients

News source: 
Anticancer Fund

New data from a retrospective study in advanced colorectal cancer patients taking aspirin concurrently indicates that it may have some positive effects on clinical outcomes.

External news